Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Chi-Fu Jeffrey Yang is a thoracic surgeon at Massachusetts General Hospital and an assistant professor of surgery at Harvard Medical School. He received his bachelor's degree in biochemistry from Harvard College and his medical degree at Harvard Medical School. He completed his general surgery residency at Duke and cardiothoracic surgery fellowship at Stanford. 

Lung Cancer Onctalk 2023 - Dr. Jeff Yang
A recorded live event where a team of top oncologists discusses emerging concepts and best practices in non-small cell lung cancer (NSCLC).
Author
Chi-Fu Jeffrey Yang, MD - Guest Faculty
Image
Lung Cancer OncTalk 2023

At our live event, Lung Cancer OncTalk 2023, Dr. Jeff Yang, discusses different surgical procedures used to treat early-stage lung cancer and different approaches to removing cancerous tissue from the lung. 

Dr. Chi-Fu Jeffrey Yang is a thoracic surgeon at Massachusetts General Hospital and an assistant professor of surgery at Harvard Medical School. He received his bachelor's degree in biochemistry from Harvard College and his medical degree at Harvard Medical School. He completed his general surgery residency at Duke and his cardiothoracic surgery fellowship at Stanford. 

Learn more about Dr. Yang here.

To watch the complete playlist click here.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora